Humana financials
$386.87−0.71%
Close Sep 29, 2026 · split-adjustedRevenue
Net income
Income statement & cash flow
| Quarter | Q2 '26 Jun 30 | Q1 '26 Mar 31 | Q4 '25 Dec 31 | Q3 '25 Sep 30 | Q2 '25 Jun 30 | Q1 '25 Mar 31 | Q4 '24 Dec 31 | Q3 '24 Sep 30 | Q2 '24 Jun 30 | Q1 '24 Mar 31 | Q4 '23 Dec 31 | Q3 '23 Sep 30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $40.87B | $39.65B | $32.38B | $32.25B | $32.39B | $32.11B | $28.92B | $29.05B | $29.54B | $29.61B | $26.17B | $26.11B |
| Gross profit | $5.50B | $5.94B | $3.66B | $4.26B | $4.82B | $5.58B | $3.54B | $3.93B | $4.50B | $4.49B | $3.39B | $4.37B |
| Gross margin | 13.5% | 15.0% | 11.3% | 13.2% | 14.9% | 17.4% | 12.2% | 13.5% | 15.2% | 15.2% | 12.9% | 16.7% |
| Operating income | $1.36B | $1.75B | -$944.0M | -$1.0M | $1.10B | $2.01B | -$840.0M | $385.0M | $1.14B | $1.24B | -$642.0M | $898.0M |
| Net income | $694.0M | $1.19B | -$796.0M | $195.0M | $545.0M | $1.24B | -$693.0M | $480.0M | $679.0M | $741.0M | -$541.0M | $832.0M |
| Net margin | 1.7% | 3.0% | −2.5% | 0.6% | 1.7% | 3.9% | −2.4% | 1.7% | 2.3% | 2.5% | −2.1% | 3.2% |
| Diluted EPS | $5.73 | $9.83 | $-6.58 | $1.62 | $4.51 | $10.30 | $-5.74 | $3.98 | $5.62 | $6.11 | $-4.39 | $6.71 |
| EBITDA | $1.55B | $1.95B | -$750.0M | $203.0M | $1.31B | $2.23B | -$600.0M | $628.0M | $1.38B | $1.48B | -$642.0M | $1.13B |
| Operating cash flow | $1.97B | $1.25B | -$1.65B | $971.0M | $1.27B | $331.0M | -$528.0M | $1.86B | $1.21B | $423.0M | -$7.13B | $1.25B |
| Free cash flow | $1.83B | $1.13B | -$1.85B | $836.0M | $1.16B | $236.0M | -$682.0M | $1.73B | $1.10B | $246.0M | -$7.42B | $1.02B |
| Diluted shares | 121.1M | 120.7M | 121.0M | 120.7M | 120.7M | 120.8M | 120.8M | 120.8M | 120.7M | 121.3M | 123.1M | 124.0M |
Balance sheet
| Period end | Jun 30 | Mar 31 | Dec 31 | Sep 30 | Jun 30 | Mar 31 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $6.89B | $4.95B | $4.20B | $5.39B | $4.04B | $4.25B |
| Short-term investments | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Total debt | $14.25B | $13.99B | $12.37B | $12.61B | $12.59B | $13.68B |
| Total assets | $57.20B | $55.28B | $48.91B | $49.72B | $50.36B | $50.93B |
| Total liabilities | $37.92B | $36.63B | $31.17B | $31.14B | $32.06B | $33.11B |
| Shareholders' equity | $19.28B | $18.65B | $17.74B | $18.58B | $18.30B | $17.82B |
From SEC filings via Massive. Fiscal periods follow the company's own calendar; free cash flow is operating cash flow minus capital expenditure.
Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology